| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 7 |
| 1 | CARBOPLATIN | 4 |
| 2 | PACLITAXEL | 4 |
| 3 | ADALIMUMAB | 3 |
| 4 | AMLODIPINE | 3 |
| 5 | ASPIRIN | 3 |
| 6 | ASPIRIN 325 MG | 3 |
| 7 | ASPIRIN 81 MG | 3 |
| 8 | BISOPROLOL FUMARATE | 3 |
| 9 | CANDESARTAN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L DOPA | 1 | 0.0037 |
| 1 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 2 | OMEGA-3-ACID ETHYL ESTERS | 1 | 0.0005 |
| 3 | CEFUROXIME | 2 | 0.0002 |
| 4 | CILOSTAZOL | 1 | 0.0002 |
| 5 | ELETRIPTAN HYDROBROMIDE | 1 | 0.0001 |
| 6 | CANDESARTAN | 3 | 0.0001 |
| 7 | CEFAZOLIN SODIUM | 1 | 0.0001 |
| 8 | BEVACIZUMAB | 7 | 0.0001 |
| 9 | LACTULOSE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |
| 3 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 6 | Insulin [EPC] | 1 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |